Schedule 13G ownership disclosure
SILEXION THERAPEUTICS CORP
Ordinary Shares, par value $0.0135 per share · CUSIP: G1281K130
Event date: 2025-09-11
- Filing-level shares
- 131,250.00
- Percent of class
- 6.2%
- Orca Capital AG
Shares: 131,250.00 · Class: 6.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-013532
- Form type
- SCHEDULE 13G
- Filer
- Orca Capital AG
- CIK
- CIK 2052389
- Filed
- Sep 15, 2025
- Reporting period
- Sep 11, 2025
- Description
- Schedule 13G beneficial ownership